These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 28296773)

  • 1. Enhanced efficacy of adjuvant chemotherapy and radiotherapy in selected cases of surgically resected neuroendocrine carcinoma of the uterine cervix: A retrospective cohort study.
    Xie S; Song L; Yang F; Tang C; Yang S; He J; Pan X
    Medicine (Baltimore); 2017 Mar; 96(11):e6361. PubMed ID: 28296773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical analysis of 32 cases with neuroendocrine carcinoma of the uterine cervix in early-stage disease].
    Wang Z; Wu L; Yao H; Sun Y; Li X; Li B; Zhang R; Ma S; Huang M
    Zhonghua Fu Chan Ke Za Zhi; 2015 Mar; 50(3):198-203. PubMed ID: 26268410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic factors in FIGO stage IB-IIA small cell neuroendocrine carcinoma of the uterine cervix treated surgically: results of a multi-center retrospective Korean study.
    Lee JM; Lee KB; Nam JH; Ryu SY; Bae DS; Park JT; Kim SC; Cha SD; Kim KR; Song SY; Kang SB
    Ann Oncol; 2008 Feb; 19(2):321-6. PubMed ID: 17962205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Factors of Surgically Treated Early-Stage Small Cell Neuroendocrine Carcinoma of the Cervix.
    Yuan L; Jiang H; Lu Y; Guo SW; Liu X
    Int J Gynecol Cancer; 2015 Sep; 25(7):1315-21. PubMed ID: 26186071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors and optimal therapy for stages I-II neuroendocrine carcinomas of the uterine cervix: A multi-center retrospective study.
    Ishikawa M; Kasamatsu T; Tsuda H; Fukunaga M; Sakamoto A; Kaku T; Nakanishi T; Hasumi Y; Iwata T; Baba T; Nogawa T; Kudaka W; Kaneda H; Ono S; Saito F; Taniguchi Y; Okada S; Mizuno M; Onda T; Yaegashi N
    Gynecol Oncol; 2018 Jan; 148(1):139-146. PubMed ID: 29113721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinicopathological features and treatment modalities associated with survival of neuroendocrine cervical carcinoma in a Chinese population.
    Zhang X; Lv Z; Lou H
    BMC Cancer; 2019 Jan; 19(1):22. PubMed ID: 30616631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small cell neuroendocrine carcinoma of the cervix: analysis of the prognosis and role of radiation therapy for 43 cases.
    Lan-Fang L; Hai-Yan S; Zuo-Ming Y; Jian-Qing Z; Ya-Qing C
    Eur J Gynaecol Oncol; 2012; 33(1):68-73. PubMed ID: 22439409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prognostic factors of stage IB and IIA carcinoma of the cervix treated by surgery].
    Zhang WH; Wu LY; Bai P; Li SM; Zhang R; Li B; Sun JH; Wu AR
    Zhonghua Zhong Liu Za Zhi; 2004 Aug; 26(8):490-2. PubMed ID: 15555341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Results of different postoperative adjuvant therapies for stage Ib-IIa cervical carcinoma with risk factors].
    Wen HW; Huang WP; Liu TY; Ma K; Tao X; Zhu LR; Liao QP
    Zhonghua Fu Chan Ke Za Zhi; 2013 Dec; 48(12):920-4. PubMed ID: 24495686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neuroendocrine carcinoma of cervix: a clinicopathologic study of 82 cases].
    Feng M; Zou J; Zhang Y; Sun L
    Zhonghua Bing Li Xue Za Zhi; 2018 May; 47(5):328-333. PubMed ID: 29783797
    [No Abstract]   [Full Text] [Related]  

  • 11. The impact of neo/adjuvant treatment choices on prognosis for surgically treated small-cell neuroendocrine carcinoma of the cervix.
    Zhao D; Sun S; Yang Z; Wang P; Qiu H
    Neoplasma; 2024 Feb; 71(1):70-76. PubMed ID: 38215035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinicopathologic analysis of small cell neuroendocrine carcinoma of the cervix].
    Qin JC; Li L; Yang ZJ; Yao DS; Li F; Zhang JQ
    Zhonghua Fu Chan Ke Za Zhi; 2011 May; 46(5):360-3. PubMed ID: 21733373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors and treatment comparison in small cell neuroendocrine cervical carcinoma.
    Yin ZM; Yu AJ; Wu MJ; Zhu JQ; Zhang X; Chen JH; Yuan SH; Yu H
    Eur J Gynaecol Oncol; 2014; 35(3):259-63. PubMed ID: 24984537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cycles of cisplatin and etoposide affect treatment outcomes in patients with FIGO stage I-II small cell neuroendocrine carcinoma of the cervix.
    Pei X; Xiang L; Ye S; He T; Cheng Y; Yang W; Wu X; Yang H
    Gynecol Oncol; 2017 Dec; 147(3):589-596. PubMed ID: 28954697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multicenter study of the importance of systemic chemotherapy for patients with small-cell neuroendocrine carcinoma of the uterine cervix.
    Lee SW; Lim KT; Bae DS; Park SY; Kim YT; Kim KR; Nam JH
    Gynecol Obstet Invest; 2015; 79(3):172-8. PubMed ID: 25500455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical response of large cell neuroendocrine carcinoma of the lung to perioperative adjuvant chemotherapy.
    Saji H; Tsuboi M; Matsubayashi J; Miyajima K; Shimada Y; Imai K; Kato Y; Usuda J; Kajiwara N; Uchida O; Ohira T; Hirano T; Mukai K; Kato H; Ikeda N
    Anticancer Drugs; 2010 Jan; 21(1):89-93. PubMed ID: 19770636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prognostic analysis of stage Ⅰb2 andⅡa2 cervical squamous cancer without high risk factors treated with neo-adjuvant chemotherapy and radical hysterectomy].
    Li PP; Li B; Wang YT; Liu SH; Zhang YN; Zhang R; Bai P; Li XG; Wu LY
    Zhonghua Fu Chan Ke Za Zhi; 2018 Apr; 53(4):248-256. PubMed ID: 29747270
    [No Abstract]   [Full Text] [Related]  

  • 18. [Analysis of prognostic factors in patients with cervical squamous cell carcinoma of stage Ib and IIa].
    Chen L; Lü WG; Xie X; Chen HZ; Yu H; Ni XH
    Zhonghua Fu Chan Ke Za Zhi; 2005 Apr; 40(4):239-42. PubMed ID: 15924669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors affecting the outcome of early cervical cancer treated with radical hysterectomy and post-operative adjuvant therapy.
    Liu MT; Hsu JC; Liu WS; Wang AY; Huang WT; Chang TH; Pi CP; Huang CY; Huang CC; Chou PH; Chen TH
    Eur J Cancer Care (Engl); 2008 Mar; 17(2):174-81. PubMed ID: 18302655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-recurrence survival in patients with cervical cancer.
    Cibula D; Dostálek L; Jarkovsky J; Mom CH; Lopez A; Falconer H; Scambia G; Ayhan A; Kim SH; Isla Ortiz D; Klat J; Obermair A; Di Martino G; Pareja R; Manchanda R; Kosťun J; Dos Reis R; Meydanli MM; Odetto D; Laky R; Zapardiel I; Weinberger V; Benešová K; Borčinová M; Cardenas F; Wallin E; Pedone Anchora L; Akilli H; Abu-Rustum NR; Barquet-Muñoz SA; Javůrková V; Fischerová D; van Lonkhuijzen LRCW
    Gynecol Oncol; 2022 Feb; 164(2):362-369. PubMed ID: 34955236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.